The ORBITA trial, a double-blind, randomized controlled study, evaluated the efficacy of percutaneous coronary intervention (PCI) compared to a placebo procedure in 200 patients with stable angina and significant single-vessel stenosis. After six weeks of medication optimization, results showed no significant difference in exercise time improvement between PCI and the
